301507 民生健康
交易中 03-11 14:52:27
资讯
新帖
简况
关注“一老一小” 守护民生健康底色
青海日报 · 04:51
关注“一老一小” 守护民生健康底色
滨江第一,淳安垫底,杭州各区县上市公司分布
浙股 · 03-08
滨江第一,淳安垫底,杭州各区县上市公司分布
民生健康新提交“金维他甄”、“二十一金维他二阶”等2件商标注册申请
证券之星 · 03-08
民生健康新提交“金维他甄”、“二十一金维他二阶”等2件商标注册申请
每周股票复盘:民生健康(301507)维生素与矿物质市场潜力巨大,公司新品销售稳步推进
证券之星 · 02-22
每周股票复盘:民生健康(301507)维生素与矿物质市场潜力巨大,公司新品销售稳步推进
民生健康最新公告:取得酒石酸伐尼克兰片药品批文
证券之星 · 02-13
民生健康最新公告:取得酒石酸伐尼克兰片药品批文
民生健康(301507.SZ)取得酒石酸伐尼克兰片药品批文
智通财经 · 02-13
民生健康(301507.SZ)取得酒石酸伐尼克兰片药品批文
民生健康新提交“肌素然”商标注册申请
证券之星 · 01-05
民生健康新提交“肌素然”商标注册申请
民生健康(301507.SZ)与中科嘉亿等主体共同签署战略合作协议
智通财经 · 2024-12-26
民生健康(301507.SZ)与中科嘉亿等主体共同签署战略合作协议
民生健康最新公告:拟通过全资子公司收购标的公司100%股权
证券之星 · 2024-12-26
民生健康最新公告:拟通过全资子公司收购标的公司100%股权
民生健康最新公告:与中科嘉亿等主体签署战略合作协议
证券之星 · 2024-12-26
民生健康最新公告:与中科嘉亿等主体签署战略合作协议
民生健康获得实用新型专利授权:“瓶贴机”
证券之星 · 2024-11-23
民生健康获得实用新型专利授权:“瓶贴机”
民生健康(301507)2024年三季报简析:营收净利润同比双双增长
证券之星 · 2024-10-30
民生健康(301507)2024年三季报简析:营收净利润同比双双增长
民生健康(301507.SZ)发布前三季度业绩,净利润8617.84万元,增长5.52%
智通财经 · 2024-10-28
民生健康(301507.SZ)发布前三季度业绩,净利润8617.84万元,增长5.52%
图解民生健康三季报:第三季度单季净利润同比减23.33%
证券之星 · 2024-10-28
图解民生健康三季报:第三季度单季净利润同比减23.33%
民生健康(301507)9月30日股东户数2.65万户,较上期减少2.78%
证券之星 · 2024-10-28
民生健康(301507)9月30日股东户数2.65万户,较上期减少2.78%
民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股
智通财经 · 2024-09-18
民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股
民生健康:辅导券商保荐人监管处罚,公司考虑继续聘用吗?
问董秘 · 2024-09-12
民生健康:辅导券商保荐人监管处罚,公司考虑继续聘用吗?
民生健康:辅导券商尽职尽责,公司保守稳健,无更换保荐人打算
问董秘 · 2024-09-12
民生健康:辅导券商尽职尽责,公司保守稳健,无更换保荐人打算
加载更多
公司概况
公司名称:
杭州民生健康药业股份有限公司
所属行业:
医药制造业
上市日期:
2023-09-05
主营业务:
杭州民生健康药业股份有限公司的主营业务是集维生素与矿物质类非处方药品和保健食品研发、生产、销售。公司的主要产品是维生素与矿物质补充剂系列产品和益生菌系列产品;经过十余年的行业深耕,公司构建了覆盖全国的终端销售网络体系,拥有较强的品牌知名度和美誉度。公司主打品牌“21金维他”,2019年上榜“健康中国品牌榜”西普金·奖锐榜,2020年上榜“健康中国·品牌榜”西普金奖药品榜,2021年度入选“2020-2021年健康产业·品牌发展指数·TOP品牌”。
发行价格:
10.00
{"stockData":{"symbol":"301507","market":"SZ","secType":"STK","nameCN":"民生健康","latestPrice":13.41,"timestamp":1741675947000,"preClose":13.49,"halted":0,"volume":3319802,"delay":0,"changeRate":-0.0059,"floatShares":111000000,"shares":357000000,"eps":0.2529,"marketStatus":"交易中","change":-0.08,"latestTime":"03-11 14:52:27","open":13.33,"high":13.44,"low":13.27,"amount":44325900,"amplitude":0.0126,"askPrice":13.41,"askSize":279,"bidPrice":13.4,"bidSize":4,"shortable":0,"etf":0,"ttmEps":0.2529,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1741676400000},"marketStatusCode":2,"adr":0,"adjPreClose":13.49,"symbolType":"stock","openAndCloseTimeList":[[1741656600000,1741663800000],[1741669200000,1741676400000]],"highLimit":14.84,"lowLimit":12.14,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":356554330,"isCdr":false,"pbRate":3.16,"roa":"--","peRate":53.024911,"roe":"5.73%","epsLYR":0.29,"committee":-0.437586,"marketValue":4781000000,"turnoverRate":0.03,"status":1,"floatMarketCap":1482000000},"requestUrl":"/m/hq/s/301507","defaultTab":"news","newsList":[{"id":"2518785560","title":"关注“一老一小”\n守护民生健康底色","url":"https://stock-news.laohu8.com/highlight/detail?id=2518785560","media":"青海日报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518785560?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:51","pubTimestamp":1741639860,"startTime":"0","endTime":"0","summary":"马福昌代表认为,为了更好地落实“健康中国”和“健康青海”战略,在全周期全方位保障我省各族人民群众身体健康的同时,应该尤为关注“一老一小”问题。在关注老年健康、提升养老服务水平方面,马福昌表示,应当在聚焦重点群体、加强兜底性基础性养老服务的同时,依托基本公共卫生服务项目,持续开展老年健康服务,广泛普及老年人健康科学知识,加强失能老年人健康服务行动。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2025-03-11/doc-inepfkuz3089178.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2517413884","title":"滨江第一,淳安垫底,杭州各区县上市公司分布","url":"https://stock-news.laohu8.com/highlight/detail?id=2517413884","media":"浙股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517413884?lang=zh_cn&edition=full","pubTime":"2025-03-08 12:04","pubTimestamp":1741406640,"startTime":"0","endTime":"0","summary":"从1993年上市的天目药业,到即将挂牌的永杰新材,杭州现有A股上市公司230家,在浙江720家中占比32%,在全国5400家中占比4.3%。杭州现有千亿市值公司两家,分别为滨江区的海康威视、余杭区的同花顺。2021年,杭州完成区划调整,现有10区、1市、2县。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/wm/2025-03-08/doc-inenxkpq3020515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["002247","300558","301203","301556","688475","603238","300451","300144","600926","000909","301507","600570","601878","688130","600797","300768","601177","301055","301157","301316","300698","301068","600120","301119","300306","603040","301092","300792","603931","300550","603300","002284","300766","300250","300582","300695","688255","301066","300853","300277","300360","001270","603551","688075","002761","300930","603071","002415","688571","300033"],"gpt_icon":0},{"id":"2517286464","title":"民生健康新提交“金维他甄”、“二十一金维他二阶”等2件商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2517286464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517286464?lang=zh_cn&edition=full","pubTime":"2025-03-08 06:32","pubTimestamp":1741386767,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日杭州民生健康药业股份有限公司新提交“金维他甄”、“二十一金维他二阶”等2件商标注册申请。商标申请详情如下:今年以来杭州民生健康药业股份有限公司新申请注册商标10件,截止目前公司共持有注册商标326件,另有85件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025030800059385.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2513424756","title":"每周股票复盘:民生健康(301507)维生素与矿物质市场潜力巨大,公司新品销售稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2513424756","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513424756?lang=zh_cn&edition=full","pubTime":"2025-02-22 09:47","pubTimestamp":1740188828,"startTime":"0","endTime":"0","summary":"截至2025年2月21日收盘,民生健康报收于12.72元,较上周的12.74元下跌0.16%。本周,民生健康2月17日盘中最高价报13.01元。由于公司涉足保健品领域晚于 OTC,目前尚未形成较大销售规模,但保健品产品的销售维持较高的增长速度,其在公司业务收入的比重逐步上升。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025022200010482.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2511558517","title":"民生健康最新公告:取得酒石酸伐尼克兰片药品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2511558517","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511558517?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:20","pubTimestamp":1739442024,"startTime":"0","endTime":"0","summary":"民生健康公告称,公司收到国家药品监督管理局核准签发的酒石酸伐尼克兰片《药品补充申请批准通知书》,该药品用于成人戒烟。此次取得药品批文,有利于进一步丰富产品品类,提升公司市场竞争力。但药品销售业务易受医药行业政策变动、市场竞争状况等因素影响,存在不确定性。以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025021300033653.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2511517891","title":"民生健康(301507.SZ)取得酒石酸伐尼克兰片药品批文","url":"https://stock-news.laohu8.com/highlight/detail?id=2511517891","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511517891?lang=zh_cn&edition=full","pubTime":"2025-02-13 18:16","pubTimestamp":1739441803,"startTime":"0","endTime":"0","summary":"智通财经APP讯,民生健康(301507.SZ)公告,公司收到国家药品监督管理局核准签发的酒石酸伐尼克兰片《药品补充申请批准通知书》。酒石酸伐尼克兰片用于成人戒烟。伐尼克兰是烟碱型乙酰胆碱受体α4β2亚型的选择性部分激动剂,对神经中该受体具有高度亲和力。伐尼克兰与α4β2受体结合产生激动作用,同时阻断尼古丁与该受体结合,从而发挥戒烟作用。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"民生健康(301507.SZ)取得酒石酸伐尼克兰片药品批文","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2501859451","title":"民生健康新提交“肌素然”商标注册申请","url":"https://stock-news.laohu8.com/highlight/detail?id=2501859451","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2501859451?lang=zh_cn&edition=full","pubTime":"2025-01-05 04:48","pubTimestamp":1736023704,"startTime":"0","endTime":"0","summary":"证券之星消息,根据企查查数据显示,近日杭州民生健康药业股份有限公司新提交“肌素然”商标注册申请。商标申请详情如下:今年以来杭州民生健康药业股份有限公司新申请注册商标0件,截止目前公司共持有注册商标326件,另有74件商标尚在注册申请中。数据来源:企查查以上内容为证券之星据公开信息整理,由智能算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025010500000165.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2494850626","title":"民生健康(301507.SZ)与中科嘉亿等主体共同签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2494850626","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494850626?lang=zh_cn&edition=full","pubTime":"2024-12-26 21:13","pubTimestamp":1735218803,"startTime":"0","endTime":"0","summary":"智通财经APP讯,民生健康 公告,公司于2024年12月23日召开第二届董事会第六次会议,审议通过了《关于与中科嘉亿等主体签署的议案》,同意公司就民生中科(浙江)收购民生中科嘉亿(山东)生物工程有限公司100%股权具体事宜,与中科嘉亿等主体共同签署《战略合作协议》。民生健康拟放弃本次民生中科(浙江)增资扩股的优先认购权,放弃权利涉及的注册资本金额为7200万元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229762.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"民生健康(301507.SZ)与中科嘉亿等主体共同签署战略合作协议","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2494647854","title":"民生健康最新公告:拟通过全资子公司收购标的公司100%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=2494647854","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494647854?lang=zh_cn&edition=full","pubTime":"2024-12-26 20:11","pubTimestamp":1735215071,"startTime":"0","endTime":"0","summary":"民生健康公告,公司拟通过全资子公司民生中科(浙江)收购标的公司100%股权。民生健康拟放弃本次民生中科(浙江)增资扩股的优先认购权,放弃权利涉及的注册资本金额为7,200万元。交易完成后,公司持有民生中科(浙江)的股权将由100%被稀释至55%,民生中科(浙江)由公司全资子公司变更为控股子公司。标的公司成为民生中科(浙江)的全资子公司并纳入公司的合并报表范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122600031094.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2494585457","title":"民生健康最新公告:与中科嘉亿等主体签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2494585457","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494585457?lang=zh_cn&edition=full","pubTime":"2024-12-26 20:10","pubTimestamp":1735215039,"startTime":"0","endTime":"0","summary":"民生健康公告,公司与中科嘉亿(山东)投资控股有限公司等主体签署了战略合作协议。民生中科(浙江)增资后,标的公司现有股东将合计持有民生中科(浙江)45%的股权。公司放弃本次民生中科(浙江)增资扩股的优先认购权,放弃权利涉及的注册资本金额为7,200万元。董事会同意授权公司经营管理层在合作协议约定范围内办理合作协议涉及相关事宜并负责后续合作事项的具体推进。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122600031093.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2485297464","title":"民生健康获得实用新型专利授权:“瓶贴机”","url":"https://stock-news.laohu8.com/highlight/detail?id=2485297464","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485297464?lang=zh_cn&edition=full","pubTime":"2024-11-23 02:22","pubTimestamp":1732299728,"startTime":"0","endTime":"0","summary":"证券之星消息,根据天眼查APP数据显示民生健康新获得一项实用新型专利授权,专利名为“瓶贴机”,专利申请号为CN202420620271.6,授权日为2024年11月22日。该瓶贴机,通过安装倒置瓶检测剔除组件,可在检测瓶子倒置时,依靠剔除气缸推动,完成对倒置瓶的剔除,具有检测瓶盖字体情况识别倒置并剔除,提升生产效率的效果,在使用时更加实用。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024112300002955.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2479402261","title":"民生健康(301507)2024年三季报简析:营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479402261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479402261?lang=zh_cn&edition=full","pubTime":"2024-10-30 06:37","pubTimestamp":1730241451,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期民生健康发布2024年三季报。根据财报显示,民生健康营收净利润同比双双增长。截至本报告期末,公司营业总收入5.2亿元,同比上升6.99%,归母净利润8617.84万元,同比上升5.52%。按单季度数据看,第三季度营业总收入1.22亿元,同比上升3.65%,第三季度归母净利润890.9万元,同比下降23.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000007554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2478748941","title":"民生健康(301507.SZ)发布前三季度业绩,净利润8617.84万元,增长5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478748941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478748941?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:30","pubTimestamp":1730107804,"startTime":"0","endTime":"0","summary":"智通财经APP讯,民生健康(301507.SZ)发布2024年三季度报告,该公司前三季度营业收入为5.2亿元,同比增长6.98%。归属于上市公司股东的净利润为8617.84万元,同比增长5.52%。归属于上市公司股东的扣除非经常性损益的净利润为8237.56万元,同比增长9.30%。基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507"],"gpt_icon":0},{"id":"2478953171","title":"图解民生健康三季报:第三季度单季净利润同比减23.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478953171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478953171?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:19","pubTimestamp":1730107164,"startTime":"0","endTime":"0","summary":"证券之星消息,民生健康2024年三季报显示,公司主营收入5.2亿元,同比上升6.99%;归母净利润8617.84万元,同比上升5.52%;扣非净利润8237.56万元,同比上升9.3%;其中2024年第三季度,公司单季度主营收入1.22亿元,同比上升3.65%;单季度归母净利润890.9万元,同比下降23.33%;单季度扣非净利润781.82万元,同比下降23.39%;负债率10.8%,投资收益423.97万元,财务费用-1668.51万元,毛利率57.47%。财报数据概要请见下图:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800023419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2478119179","title":"民生健康(301507)9月30日股东户数2.65万户,较上期减少2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478119179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478119179?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:09","pubTimestamp":1730106555,"startTime":"0","endTime":"0","summary":"证券之星消息,近日民生健康披露,截至2024年9月30日公司股东户数为2.65万户,较6月30日减少757.0户,减幅为2.78%。在化学制药行业个股中,民生健康股东户数低于行业平均水平,截至9月30日,化学制药行业平均股东户数为3.14万户。从股价来看,2024年6月30日至2024年9月30日,民生健康区间涨幅为11.49%,在此期间股东户数减少757.0户,减幅为2.78%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800022868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2468858589","title":"民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468858589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468858589?lang=zh_cn&edition=full","pubTime":"2024-09-18 20:32","pubTimestamp":1726662765,"startTime":"0","endTime":"0","summary":"智通财经APP讯,民生健康(301507.SZ)公告,公司于2024年9月18日向2024年限制性股票激励计划激励对象首次授予限制性股票332万股,授予价格为6.67元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2466226919","title":"民生健康:辅导券商保荐人监管处罚,公司考虑继续聘用吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2466226919","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466226919?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:17","pubTimestamp":1726132620,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! 投资者提问:公开信息显示,公司辅导券商的保荐人近三年内有受过监管处罚,请问公司是否考虑继续聘用。董秘回答(民生健康SZ301507):尊敬的投资者您好,感谢对公司的关注。根据《深圳证券交易所创业板股票上市规则》等有关规定,首次公开发行股票的,保荐机构持续督导期间为股票上市当年剩余时间及其后三个完整会计年度,保荐机构履行持续督导职责符合相关规定,谢谢!查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuk7570189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2466226948","title":"民生健康:辅导券商尽职尽责,公司保守稳健,无更换保荐人打算","url":"https://stock-news.laohu8.com/highlight/detail?id=2466226948","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466226948?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:14","pubTimestamp":1726132440,"startTime":"0","endTime":"0","summary":"投资者提问:上市之后辅导券商是否尽职尽责,感觉公司这几年都比较保守,是否有更换辅导券商的打算董秘回答(民生健康SZ301507):尊敬的投资者您好,感谢对公司的关注。保荐机构和保荐代表人在持续督导期间已根据证监会及交易所有关制度规定正常履行持续督导职责,公司无更换保荐人的打算,谢谢!查看更多董秘问答>>免责声明:本信息由新浪财经从公开信息中摘录,不构成任何投资建议;新浪财经不保证数据的准确性,内容仅供参考。\n\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuq3189963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301507"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1741675952064,"stockEarnings":[{"period":"1week","weight":-0.003},{"period":"1month","weight":0.0698},{"period":"3month","weight":-0.0189},{"period":"6month","weight":0.2045},{"period":"1year","weight":0.0537},{"period":"ytd","weight":0.063}],"compareEarnings":[{"period":"1week","weight":0.0148},{"period":"1month","weight":0.0189},{"period":"3month","weight":-0.0165},{"period":"6month","weight":0.2367},{"period":"1year","weight":0.1051},{"period":"ytd","weight":0.0043}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"杭州民生健康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26480人(较上一季度减少2.78%)","perCapita":"4174股","listingDate":"2023-09-05","address":"浙江省杭州市临平区东湖街道新天路101号","registeredCapital":"35655万元","survey":" 杭州民生健康药业股份有限公司的主营业务是集维生素与矿物质类非处方药品和保健食品研发、生产、销售。公司的主要产品是维生素与矿物质补充剂系列产品和益生菌系列产品;经过十余年的行业深耕,公司构建了覆盖全国的终端销售网络体系,拥有较强的品牌知名度和美誉度。公司主打品牌“21金维他”,2019年上榜“健康中国品牌榜”西普金·奖锐榜,2020年上榜“健康中国·品牌榜”西普金奖药品榜,2021年度入选“2020-2021年健康产业·品牌发展指数·TOP品牌”。","listedPrice":10},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.31.5","shortVersion":"4.31.5","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"民生健康,301507,民生健康股票,民生健康股票老虎,民生健康股票老虎国际,民生健康行情,民生健康股票行情,民生健康股价,民生健康股市,民生健康股票价格,民生健康股票交易,民生健康股票购买,民生健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}